Navigation Links
Regulation Suggested For Private Medical Screening

According to a senior medical advisor, a crackdown on private medical screening has been planned// by government. This is due to the pressure it puts on the NHS and is also not regulated properly.

Sir Muir Grey, the program director of National Screening Committee (NSC), told the medical magazine Pulse that there needs to be a regulation of tests conducted by the private health sector. The medical screening offered by the private firms can range from a cheap cholesterol test to a whole body scan costing thousands of pounds. This might cause anxiety among the patients.

Sir Grey also added that they are contemplating measures to control private testing as it is a low value activity which creates work for health service sector but may not be beneficial to the individual. He feels that the independent sector does not have a proper system of regulation. The regulative measures which are planned to be introduced would be evidence based which could be from the healthcare commission, advertising standards authority or from office of fair trading.

Professor Mayur Lakhani, chairman of the Royal College of General Practitioners, told the magazine that medical screening has become widely accepted but is harmful if national standards are not adhered to. Richard Hoey, deputy editor of Pulse stated that it is difficult to stop patients from undergoing private screening but it has to be regulated.


Page: 1

Related medicine news :

1. Platelets May Be The Source Of Gene Regulations
2. Novel Rules And Regulations For Cardiovascular Catheterization Labs.
3. microRNA And Its Role In Synaptic Regulation
4. Nervous System Plays Role In Stem Cell Regulation
5. Bill for Formal Regulation of Tanning Salons
6. Study Highlights Appetite Regulation Pathway, New Hope for Weight Loss
7. WHO Calls For More Regulation On Tobacco Products
8. Site of Sleep Regulation Identified in Fruit Flies
9. Mechanism of Stem Cell Regulation Identified
10. Natural Approach to Immune Regulation May Help Transplant Patients
11. Regulation of Infertility Clinics Needed
Post Your Comments:

(Date:6/25/2016)... Long Beach, CA (PRWEB) , ... June 25, 2016 , ... ... from UCLA with Magna Cum Laude and his M.D from the David Geffen School ... San Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of ... recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at Work ... Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... awareness about the dangers associated with chronic pain and the benefits of holistic treatments, ... for individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) ...
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: